OnabotulinumtoxinA effects on trigeminal nociceptors
Cephalalgia · 2023
DOI: 10.1177/03331024221141683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cephalalgia, 2023. Verfasst von Ashley A Moore und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Duke University, Durham, NC, USA. Hauptthemen laut MEDLINE: Transient Receptor Potential Channels, Botulinum Toxins, Type A. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
Background
OnabotulinumtoxinA (onabotA) is approved globally for prevention of chronic migraine; however, the classical mechanism of action of onabotA in motor and autonomic neurons cannot fully explain the effectiveness of onabotulinumtoxinA in this sensory neurological disease. We sought to explore the direct effects of onabotulinumtoxinA on mouse trigeminal ganglion sensory neurons using an inflammatory soup-based model of sensitization.
Methods
Primary cultured trigeminal ganglion neurons were pre-treated with inflammatory soup, then treated with onabotulinumtoxinA (2.75 pM). Treated neurons were used to examine transient receptor potential vanilloid subtype 1 and transient receptor potential ankyrin 1 cell-surface expression, calcium influx, and neuropeptide release.
Results
We found that onabotulinumtoxinA cleaved synaptosomal-associated protein-25 kDa in cultured trigeminal ganglion neurons; synaptosomal-associated protein-25 kDa cleavage was enhanced by inflammatory soup pre-treatment, suggesting greater uptake of toxin under sensitized conditions. OnabotulinumtoxinA also prevented inflammatory soup-mediated increases in TRPV1 and TRPA1 cell-surface expression, without significantly altering TRPV1 or TRPA1 protein expression in unsensitized conditions. We observed similar inhibitory effects of onabotulinumtoxinA on TRP-mediated calcium influx and TRPV1- and TRPA1-mediated release of calcitonin gene-related peptide and prostaglandin 2 under sensitized, but not unsensitized control, conditions.
Conclusions
Our data deepen the understanding of the sensory mechanism of action of onabotulinumtoxinA and support the notion that, once endocytosed, the cytosolic light chain of onabotulinumtoxinA cleaves synaptosomal-associated protein-25 kDa to prevent soluble N-ethylmaleimide-sensitive factor attachment protein receptor-mediated processes more generally in motor, autonomic, and sensory neurons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Duke University, Durham, NC, USA.
- Allergan, an AbbVie company, Irvine, CA, USA.
- Department of Neurology, University of California, Irvine, Irvine, CA, USA.
- Department of Molecular Pathobiology - Dental Pain Research, New York University College of Dentistry, New York, NY, USA.
ORCID-Profile: Mitchell F Brin
Förderung
- NINDS NIH HHS
Zitieren
APA
Moore, A. A., Nelson, M., Wickware, C., Choi, S., Moon, G., Xiong, E., Orta, L., Brideau-Andersen, A., Brin, M. F., Broide, R. S., Liedtke, W., & Moore, C. (2023). OnabotulinumtoxinA effects on trigeminal nociceptors. Cephalalgia. https://doi.org/10.1177/03331024221141683
Vancouver
Moore AA, Nelson M, Wickware C, Choi S, Moon G, Xiong E, et al. OnabotulinumtoxinA effects on trigeminal nociceptors. Cephalalgia. 2023. doi:10.1177/03331024221141683
BibTeX
@article{Moore2023,
author = {Moore, Ashley A and Nelson, Mariana and Wickware, Christopher and Choi, Shinbe and Moon, Gene and Xiong, Emma and Orta, Lily and Brideau-Andersen, Amy and Brin, Mitchell F and Broide, Ron S and Liedtke, Wolfgang and Moore, Carlene},
title = {OnabotulinumtoxinA effects on trigeminal nociceptors},
journal = {Cephalalgia},
year = {2023},
doi = {10.1177/03331024221141683}
}
EUVIMED